About NanoCellect Biomedical
NanoCellect Biomedical is a company based in San Diego (United States) founded in 2009 by William Alaynick and Jose Morachis.. NanoCellect Biomedical has raised $78.15 million across 23 funding rounds from investors including Agilent, NIH and HHS. The company has 84 employees as of December 31, 2021. NanoCellect Biomedical offers products and services including WOLF G2 Cell Sorter, VERLO Image-guided Cell Sorter, N1 Single-Cell Dispenser, and CS1 Chiller-Stirrer. NanoCellect Biomedical operates in a competitive market with competitors including ThinkCyte, Singulex, Cell Microsystems, Silicon Biosystems and Immunicon, among others.
- Headquarter San Diego, United States
- Employees 84 as on 31 Dec, 2021
- Founders William Alaynick, Jose Morachis
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nanocellect Biomedical Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$78.15 M (USD)
in 23 rounds
-
Latest Funding Round
$28.93 M (USD), Series D
Jun 29, 2023
-
Investors
Agilent
& 12 more
-
Employee Count
84
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NanoCellect Biomedical
NanoCellect Biomedical offers a comprehensive portfolio of products and services, including WOLF G2 Cell Sorter, VERLO Image-guided Cell Sorter, N1 Single-Cell Dispenser, and CS1 Chiller-Stirrer. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Benchtop device for gentle microfluidic cell sorting with high viability.
Image-based tool for precise cell sorting in research applications.
Accessory for single-cell deposition in multi-well plates.
Device for temperature control of samples during sorting.
Unlock access to complete
Unlock access to complete
Funding Insights of NanoCellect Biomedical
NanoCellect Biomedical has successfully raised a total of $78.15M across 23 strategic funding rounds. The most recent funding activity was a Series D round of $28.93 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Series D — $28.9M
-
First Round
First Round
(31 Aug 2010)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Series D - NanoCellect Biomedical | Valuation |
investors |
|
| Aug, 2022 | Amount | Grant - NanoCellect Biomedical | Valuation |
investors |
|
| Aug, 2022 | Amount | Grant - NanoCellect Biomedical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NanoCellect Biomedical
NanoCellect Biomedical has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Agilent, NIH and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage private equity investments are pursued across diverse sectors.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Health tech startups are invested in by Illumina Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NanoCellect Biomedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NanoCellect Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanocellect Biomedical Comparisons
Competitors of NanoCellect Biomedical
NanoCellect Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ThinkCyte, Singulex, Cell Microsystems, Silicon Biosystems and Immunicon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| domain | founded_year | HQ Location |
Single-molecule counting technology is developed for cardiovascular biomarker detection.
|
|
| domain | founded_year | HQ Location |
Developer of a technology to isolate and recover single cells for molecular analysis
|
|
| domain | founded_year | HQ Location |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| domain | founded_year | HQ Location |
Cell and molecular-based diagnostics for cancer management are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nanocellect Biomedical
Frequently Asked Questions about NanoCellect Biomedical
When was NanoCellect Biomedical founded?
NanoCellect Biomedical was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Where is NanoCellect Biomedical located?
NanoCellect Biomedical is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of NanoCellect Biomedical?
Chris Neary is the current CEO of NanoCellect Biomedical.
Is NanoCellect Biomedical a funded company?
NanoCellect Biomedical is a funded company, having raised a total of $78.15M across 23 funding rounds to date. The company's 1st funding round was a Grant of $1.76M, raised on Aug 31, 2010.
How many employees does NanoCellect Biomedical have?
As of Dec 31, 2021, the latest employee count at NanoCellect Biomedical is 84.
What does NanoCellect Biomedical do?
NanoCellect Biomedical is a developer of molecular diagnostics, and improve personalized medicine. The company offers WOLF Cell Sorter, which uses a closed fluid-path microfluidic cartridge that enables cell sorting, and avoids biohazard and shear stress issues associated with traditional cell sorters. It claims that this technology sorts cells at the highest purity with almost no loss of viability. This technology has downstream applications of gene expression and sequencing. It also used in sorting rare cells such as circulating tumor cells (CTCs) from blood samples.
Who are the top competitors of NanoCellect Biomedical?
NanoCellect Biomedical's top competitors include ThinkCyte, Silicon Biosystems and Singulex.
What products or services does NanoCellect Biomedical offer?
NanoCellect Biomedical offers WOLF G2 Cell Sorter, VERLO Image-guided Cell Sorter, N1 Single-Cell Dispenser, and CS1 Chiller-Stirrer.
Who are NanoCellect Biomedical's investors?
NanoCellect Biomedical has 13 investors. Key investors include Agilent, NIH, HHS, Warburg Pincus, and National Institute of General Medical Sciences.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.